NAT2 and CYP2E1 polymorphisms associated with antituberculosis drug-induced hepatotoxicity in Chinese patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

NAT2 and CYP2E1 polymorphisms associated with antituberculosis drug-induced hepatotoxicity in Chinese patients

Published:2012-05-29 Issue:6 Volume:39 Page:535-543
ISSN:0305-1870
Container-title:Clinical and Experimental Pharmacology and Physiology
language:en
Short-container-title:Clin Exp Pharmacol Physiol

Author:

An Hui-Ru¹,Wu Xue-Qiong¹,Wang Zhong-Yuan¹,Zhang Jun-Xian¹,Liang Yan¹

Affiliation:

1. Institute of Tuberculosis Research; 309th Hospital of Chinese People's Liberation Army; Beijing; China

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1681.2012.05713.x/fullpdf

Reference26 articles.

1. Monitoring and management of antituberculosis drug induced hepatotoxicity;Agal;J. Gastroenterol. Hepatol.,2005

2. The influence of risk factors on the severity of antituberculosis drug-induced hepatotoxicity;Fernández-Villar;Int. J. Tuberc. Lung Dis.,2004

3. Tuberculosis;Frieden;Lancet,2003

4. Isoniazid: Metabolic aspects and toxicological correlated;Preziosi;Curr. Drug Metab.,2007

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isoniazid-induced liver injury risk level in different variants of N-acetyltransferase 2 (NAT2) polymorphisms: A literature review;Pharmacia;2023-10-04

2. Association of Cytochrome P450 2E1 and N- Acetyltransferase 2 Genotypes with Serum Isoniazid Level and Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Cross-Sectional Study;IRAN J MED SCI;2023

3. Polymorphisms in drug metabolism genes as a risk factor for first-line anti-tuberculosis drug-induced liver injury;Molecular Biology Reports;2022-12-23

4. NAT2 polymorphism and clinical factors that increase antituberculosis drug-induced hepatotoxicity;Pharmacogenomics;2022-06

5. Relevance of gene polymorphisms of NAT2 and NR1I2 to anti-tuberculosis drug-induced hepatotoxicity;Xenobiotica;2022-05-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3